Page last updated: 2024-12-07

3'-o-(n-methylanthraniloyl) atp

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID123756
CHEMBL ID254869
SCHEMBL ID15772869
MeSH IDM0132198

Synonyms (22)

Synonym
21h,23h-porphine-2,18-dipropanoic acid, 3,7,13,17-tetramethyl-
85287-56-5
chemid085287565
adenosine 5'-(tetrahydrogen triphosphate), 3'-(2-(methylamino)benzoate)
3'-o-n-methylanthraniloyl-atp
adenosine, 3'-[2-(methylamino)benzoate] 5'-(tetrahydrogen triphosphate)
adenosine 5'-(tetrahydrogen triphosphate), 3'-[2-(methylamino)benzoate] (9ci)
3'-o-[2-(methylamino)benzoyl]adenosine 5'-(tetrahydrogen triphosphate)
2'(3')-o-(n-methylanthraniloyl)-adenosine 5'-triphosphate
CHEMBL254869 ,
[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy(phosphonooxy)phosphoryl]oxyphosphoryl]oxymethyl]oxolan-3-yl] 2-(methylamino)benzoate
3''-o-[2-(methylamino)benzoyl]adenosine 5''-(tetrahydrogen triphosphate)
bdbm50206817
mant-atp
(2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-4-hydroxy-2-((hydroxy(hydroxy(phosphonooxy)phosphoryloxy)phosphoryloxy)methyl)tetrahydrofuran-3-yl 2-(methylamino)benzoate
mantatp
3'-o-(n-methylanthraniloyl) atp
DTXSID70234491
SCHEMBL15772869
3'-o-{[2-(methylamino)phenyl]carbonyl}adenosine 5'-(tetrahydrogen triphosphate)
Q27464150
3'-o-(n'-methyl-anthraniloyl)-adenosine-5'-o-triphosphate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Calmodulin-sensitive adenylate cyclaseBacillus anthracisKi0.98000.98000.98000.9800AID455557
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Molecular Functions (1)

Processvia Protein(s)Taxonomy
adenylate cyclase activityCalmodulin-sensitive adenylate cyclaseBacillus anthracis
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID310935Inhibition of adenylyl cyclase2007Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8
A conformational transition in the adenylyl cyclase catalytic site yields different binding modes for ribosyl-modified and unmodified nucleotide inhibitors.
AID455557Inhibition of Bacillus anthracis edema factor catalytic domain by radiometric assay2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Synthesis of a hydrolytically stable, fluorescent-labeled ATP analog as a tool for probing adenylyl cyclases.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (73)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (2.74)18.7374
1990's24 (32.88)18.2507
2000's30 (41.10)29.6817
2010's15 (20.55)24.3611
2020's2 (2.74)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.42 (24.57)
Research Supply Index4.30 (2.92)
Research Growth Index5.72 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other73 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]